Related Experiment Video
Updated: May 19, 2026

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
Published on: May 5, 2022
Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten
Aakash Bavishi1, Dean Marella2, Jonathan H Kim3
1Department of Medicine, Division of Cardiology, University of Illinois College of Medicine, Chicago, Illinois, USA.
Managing exercise-induced left ventricular outflow tract obstruction (LVOTO) in athletes with hypertrophic cardiomyopathy (HCM) is difficult. Mavacamten effectively resolved LVOTO in a professional athlete, enabling a safe return to competition.
Area of Science:
- Cardiology
- Sports Medicine
- Pharmacology
Background:
- Left ventricular outflow tract obstruction (LVOTO) in athletes with hypertrophic cardiomyopathy (HCM) presents management challenges, especially with exercise-induced obstruction.
- Medical therapies for HCM-related LVOTO can be poorly tolerated by athletes.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Valve Prolapse II: Assessment and Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

